Booking an appointment at our dental clinic is as easy as it gets...

You will be able to schedule a convenient time for your meeting with our dentists with just 2 clicks!

Book an Appointment

Dr.Mark Hoffman

Dr. Mark Hoffman's dental clinic welcomes you!

Book an Appointment

The StimGuard Clinical Trial is currently enrolling!

If you are dealing with OAB symptoms, you may be eligible to participate in the PROTECT Study, a Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of CAN-Stim of the Tibial Nerve versus Sacral Nerve Stimulation (SNS) in the treatment of Urinary Urgency Incontinence resulting from Refractory Overactive Bladder (OAB).

In this study, enrolled subjects are randomized 1:1 to receive either a StimGuard CAN-Stim or Medtronic InterStim® System. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.

Subjects will be recruited based on their ability to meet the inclusion/exclusion criteria.

For a complete list of the PROTECT Study inclusion/exclusion criteria, or to locate a clinical study site near you, please contact us.

CAN-Stim System

The CAN-Stim System is an investigational device based on wireless neuromodulation technology and is implanted using a minimally invasive procedure. This technology includes an implanted stimulator with an embedded receiver. The energy source is a small, external, rechargeable transmitter, which is worn by the subject.

The CAN-Stim System provides treatment by delivering small controlled electrical pulses to the tibial nerve. These impulses travel to the sacral nerve plexus, the group of nerves at the base of the spine responsible for bladder function.


About StimGuard

StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urinary management.